case_images: PMC10807942_01
case_images: CT in April 2020 showed tumors extending from the right bladder wall to the right lower ureter (a) (arrow) with right pelvic lymph node metastasis (b) (arrow) and lung metastases (c) (arrow).
case_images: CRIU2024-5586448.001.jpg
case_images: PMC10807942_01_CRIU2024-5586448.001.jpg
case_images: fig1
case_images: Computed tomography (CT) showed tumors extending from the right bladder wall to the right lower ureter with right pelvic lymph node and lung metastases (Figure 1).
case_images: Pathological findings following transurethral resection of bladder tumors reveal invasive urothelial carcinoma, G2 high grade (a) and PD-L1 negative (b). Internal control macrophages are positive (arrow).
case_images: CRIU2024-5586448.002.jpg
case_images: PMC10807942_01_CRIU2024-5586448.002.jpg
case_images: fig2
case_images: Pathological findings obtained following transurethral resection of bladder tumors revealed invasive urothelial carcinoma, G2 high grade (Figure 2).
case_images: (a) CT in May 2022 showed new multiple lung metastases (arrow). (b) CT in July 2022 showed that the metastatic lesions had notably reduced in size, and no new lesion was detected.
case_images: CRIU2024-5586448.003.jpg
case_images: PMC10807942_01_CRIU2024-5586448.003.jpg
case_images: fig3
case_images: Follow-up CT in May 2022 showed new multiple lung metastases (Figure 3(a)). CT in July 2022 showed that the metastatic lesions had notably reduced in size, and no new lesion was detected (Figure 3(b)).